Charles River Laboratories International Inc [NYSE: CRL] closed the trading session at $136.97.
The stocks have a year to date performance of -25.80 percent and weekly performance of 15.47 percent. The stock has been moved at -24.31 percent over the last six months. The stock has performed 2.16 percent around the most recent 30 days and changed -17.42 percent over the most recent 3-months.
If compared to the average trading volume of 1.73M shares, CRL reached to a volume of 4234479 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Charles River Laboratories International Inc [CRL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRL shares is $149.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRL stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Charles River Laboratories International Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 21, 2025. While these analysts kept the previous recommendation, Citigroup raised their target price from $155 to $175. The new note on the price target was released on March 04, 2025, representing the official price target for Charles River Laboratories International Inc stock. Previously, the target price had yet another raise to $188, while Redburn Atlantic analysts kept a Neutral rating on CRL stock.
The Average True Range (ATR) for Charles River Laboratories International Inc is set at 8.52, with the Price to Sales ratio for CRL stock in the period of the last 12 months amounting to 1.66. The Price to Book ratio for the last quarter was 2.02, with the Price to Cash per share for the same quarter was set at 4.16. Price to Free Cash Flow for CRL in the course of the last twelve months was 13.41 with Quick ratio for the last quarter at 1.13.
CRL stock trade performance evaluation
Charles River Laboratories International Inc [CRL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.47. With this latest performance, CRL shares gained by 2.16% in over the last four-week period, additionally sinking by -24.31% over the last 6 months – not to mention a drop of -41.33% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRL stock in for the last two-week period is set at 59.40, with the RSI for the last a single of trading hit 69.72, and the three-weeks RSI is set at 53.41 for Charles River Laboratories International Inc [CRL]. The present Moving Average for the last 50 days of trading for this stock 141.95, while it was recorded at 121.43 for the last single week of trading, and 179.22 for the last 200 days.
Charles River Laboratories International Inc [CRL]: An insightful look at the core fundamentals
Charles River Laboratories International Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.13 and a Current Ratio set at 1.41.
Earnings per share (EPS) analysis for Charles River Laboratories International Inc [CRL] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Charles River Laboratories International Inc go to 2.69%.
Charles River Laboratories International Inc [CRL]: Institutional Ownership
The top three institutional holders of CRL stocks are: VANGUARD GROUP INC with ownership of 6.1 million shares, which is approximately 11.8396%. BLACKROCK INC., holding 5.09 million shares of the stock with an approximate value of $$1.05 billion in CRL stocks shares; and BLACKROCK INC., currently with $$431.52 million in CRL stock with ownership which is approximately 4.052%.
